This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1996;18(1):125-48.

doi: 10.1007/BF00792613.

Mechanisms of action of interferon-beta in multiple sclerosis

B G Arnason¹, A Dayal, Z X Qu, M A Jensen, K Genç, A T Reder

Affiliations

PMID: 8984676
DOI: 10.1007/BF00792613

Review

Mechanisms of action of interferon-beta in multiple sclerosis

B G Arnason et al. Springer Semin Immunopathol. 1996.

. 1996;18(1):125-48.

doi: 10.1007/BF00792613.

Authors

B G Arnason¹, A Dayal, Z X Qu, M A Jensen, K Genç, A T Reder

Affiliation

¹ Department of Neurology and the Brain Research Institute, University of Chicago, IL 60637, USA.

PMID: 8984676
DOI: 10.1007/BF00792613

No abstract available

PubMed Disclaimer

Similar articles

Targets for the therapeutic action of interferon-beta in multiple sclerosis.
Hartung HP, Kieseier BC. Hartung HP, et al. Ann Neurol. 1996 Dec;40(6):825-6. doi: 10.1002/ana.410400602. Ann Neurol. 1996. PMID: 9007085 No abstract available.
[Interferon-1 beta in the treatment of multiple sclerosis].
[No authors listed] [No authors listed] Nervenarzt. 1995 Sep;66(9 Suppl Interferon):1-16. Nervenarzt. 1995. PMID: 9131093 German. No abstract available.
Interferon beta treatment of multiple sclerosis.
Markovitz DI. Markovitz DI. Neurology. 1994 Jan;44(1):186; author reply 188-90. doi: 10.1212/wnl.44.1.186. Neurology. 1994. PMID: 8290070 No abstract available.
[Interferon beta and copolymer-1: mechanism of action and clinical effects in multiple sclerosis].
Losy J. Losy J. Neurol Neurochir Pol. 2000;34(3 Suppl):63-9. Neurol Neurochir Pol. 2000. PMID: 10983302 Review. Polish.
[Pathogenetic basis for using interferon-beta preparations in treating multiple sclerosis].
Cheknev SB. Cheknev SB. Vestn Ross Akad Med Nauk. 2001;(12):45-8. Vestn Ross Akad Med Nauk. 2001. PMID: 11845782 Review. Russian. No abstract available.

See all similar articles

Cited by

The mechanism of action of interferon-β in relapsing multiple sclerosis.
Kieseier BC. Kieseier BC. CNS Drugs. 2011 Jun 1;25(6):491-502. doi: 10.2165/11591110-000000000-00000. CNS Drugs. 2011. PMID: 21649449 Review.
Disease-modifying therapies and infectious risks in multiple sclerosis.
Winkelmann A, Loebermann M, Reisinger EC, Hartung HP, Zettl UK. Winkelmann A, et al. Nat Rev Neurol. 2016 Apr;12(4):217-33. doi: 10.1038/nrneurol.2016.21. Epub 2016 Mar 4. Nat Rev Neurol. 2016. PMID: 26943779 Review.
Regulation and function of class II major histocompatibility complex, CD40, and B7 expression in macrophages and microglia: Implications in neurological diseases.
O'Keefe GM, Nguyen VT, Benveniste EN. O'Keefe GM, et al. J Neurovirol. 2002 Dec;8(6):496-512. doi: 10.1080/13550280290100941. J Neurovirol. 2002. PMID: 12476345 Review.
Long-term treatment of multiple sclerosis with interferon-beta may be cost effective.
Kendrick M, Johnson KI. Kendrick M, et al. Pharmacoeconomics. 2000 Jul;18(1):45-53. doi: 10.2165/00019053-200018010-00005. Pharmacoeconomics. 2000. PMID: 11010603 Review.
Biological activity of interferon betas in patients with multiple sclerosis is affected by treatment regimen and neutralising antibodies.
Bertolotto A, Sala A, Malucchi S, Marnetto F, Caldano M, Di Sapio A, Capobianco M, Gilli F. Bertolotto A, et al. J Neurol Neurosurg Psychiatry. 2004 Sep;75(9):1294-9. doi: 10.1136/jnnp.2004.037259. J Neurol Neurosurg Psychiatry. 2004. PMID: 15314118 Free PMC article. Clinical Trial.

See all "Cited by" articles

References

1. Ann Immunol (Paris). 1978 Feb-Mar;129(2-3):159-70 - PubMed
1. Am J Ther. 1995 Sep;2(9):711-720 - PubMed
1. J Immunol. 1991 Sep 15;147(6):1792-6 - PubMed
1. Proc Natl Acad Sci U S A. 1992 May 1;89(9):4076-80 - PubMed
1. J Virol. 1988 Jan;62(1):114-9 - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information